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PAIN, SEVERITY, AND ATTENTIONAL CAPACITY FOLLOWING ACUTE 
MUSCULOSKELETAL INJURY 
by 
REBEKAH ROESSLER 
(Under the Direction of Jessica Mutchler) 
ABSTRACT 
Background: As recreational activities grow in popularity, there is a concurrent rise in 
musculoskeletal injury. Injury severity is determined through clinical evaluation and defined by a 
grading scale. Pain is included in the definition of each injury grade, despite the lack of any 
conclusive evidence relating injury severity and the associated pain. Additionally, previous 
studies report impairments in cognitive performance due to chronic and acute pain. The aim of 
this study is to determine the relationship between the perceived pain intensity and the clinically 
diagnosed severity of an acute musculoskeletal injury, and to determine if attentional capacity is 
influenced by the presence of acute pain.  
Methods: This study was completed in two parts. Part one included sixteen recreationally active 
participants clinically diagnosed within 24 hours of an acute musculoskeletal injury. Of those, 
five participated in part two and were tested on attentional capacity. Participants were re-tested 
on all attentional tests when pain free. Pain intensity was measured with the Visual Analog Scale 
(VAS). Attention tasks included the Trail Making Test A (TMT-A), Trail Making Test B (TMT-
B) and the D-KEFS Color Word Interference Test (CWIT). A Spearman’s Rho determined the 
relationship between grade of injury and pain intensity. The Wilcoxon signed-rank test 
determined correlations in attentional performance while in acute pain and once pain-free. Both 
statistical tests used an alpha level of p > 0.05 a priori.  
  
Results: No significant relationship was found between grade of injury and pain intensity (p = 
0.84). Participants had significantly improved performance on the CWIT-1 (p = 0.04) and 
CWIT-4 (p = 0.04) once pain-free. No significant difference was observed between acute pain 
and pain-free states for TMT-B (p = 0.07), CWIT-2 (p = 0.46), or CWIT-3 (p = 0.14).  
Conclusion: Results from this study suggest pain intensity and injury severity are not related, and 
attentional impairments may be present in patients suffering from acute musculoskeletal injury.  
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CHAPTER 1 
INTRODUCTION 
 Involvement in recreational activities, such as running, intramural sport, and weightlifting 
are growing in popularity as the general population seeks to maintain a healthy lifestyle. In 2018, 
an estimated 218.5 million Americans took part in sports and other activities, 1.6 million more 
participants than in 2017.1 As the number of individuals participating in recreational activities 
continues to rise, there is a corresponding increase in resultant musculoskeletal injury.2 The pain 
often associated with musculoskeletal injury is a subjective experience that acts as a signal, 
alerting a person to the injury and prompting a decrease in activity or need to seek help.3 
Currently, there is no evidence to support a relationship between pain levels experienced and the 
actual severity of an injury.4 Further, pain is a known attention-demanding process, and may 
therefore have an effect on cognition.5 
Musculoskeletal injury involves damage to bones, muscles, tendons, or ligaments of the 
body due to physical trauma. A thorough clinical examination determines the severity of injury 
based on anatomical damage, clinical presentation, functional loss, and mechanism of trauma.6 
One common grading scale describes the severity of a muscular or ligamentous injury as the 
following: grade 1 is a stretching of the tissue with local pain and point tenderness; grade 2 is a 
partial tearing of the tissue with moderate pain; and grade 3 is a complete rupture of the tissue 
with pain present for muscular injuries, but often limited in ligamentous injury due to tearing of 
the local nerves.7 Despite the lack of evidence to support pain intensity as a useful predictor for 
severity of musculoskeletal injury, current level of pain intensity is considered part of the clinical 
assignment of injury severity.4,8 
7 
 
 
Pain is defined by the International Association for the Study of Pain (IASP) as “an 
unpleasant sensory and emotional experience associated with actual or potential tissue damage, 
or described in terms of such damage.”9 This definition highlights the lack of congruency 
between pain and actual tissue damage, as well as the influence of unique sensory and emotional 
factors on the overall experience.5 Although pain is an important component to any injury, pain 
that is non proportional to the assessed tissue damage should not overshadow objective findings 
in a clinical evaluation. To the researcher’s knowledge, there are no studies differentiating 
between assessed injury severity through clinical evaluation, and the associated perceived pain 
intensity.  
Not only does subjective pain intensity influence the clinician’s grading of injury 
severity, it may also influence patients’ ability to receive and process information given to them 
by the clinician during initial evaluation. Pain processing and cognitive function are two separate 
processes that share the same neural regions, and therefore, must share the same neural 
resources.10 The two regions in the brain that are most commonly stimulated by pain include the 
anterior cingulate cortex (ACC) and the prefrontal cortex (PFC).11,12 In addition to pain, the ACC 
and PFC are engaged with cognitive tasks such as attention.13,14  Cognition may become 
disrupted as neural resources are drawn towards the presence of pain, which is known to be 
interruptive, distracting, and difficult to disengage from.5,10,15 Evidence from fMRI, PET, and 
EEG studies further support that pain and cognitive related activity have a modulating effect on 
one another.10 Chronic pain patients frequently present with cognitive impairment and decreased 
performance on neuropsychological tests.16 A meta-analysis described the pooled results from 
five studies demonstrating impaired attentional shifting in chronic pain patients as measured with 
the Stroop Test.15 Although there is a large body of literature dedicated to chronic pain and 
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cognitive functioning, few studies have examined the effect that acute musculoskeletal pain and 
injury may have on cognitive processes.17,18 
The purpose of this study was to determine the relationship between the perceived pain 
intensity and the clinically diagnosed severity of an acute musculoskeletal injury. This study 
further sought to determine if attentional capacity performance is influenced by the presence of 
acute pain. It was hypothesized that no relationship exists between the pain and severity of an 
acute musculoskeletal injury. It was further hypothesized that attentional capacity performance 
would be improved in a pain-free state as compared to while experiencing acute pain.  
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CHAPTER 2 
METHODOLOGY 
Experimental Design 
Recreationally active participants between the ages of 18-30 years were studied to 
determine the relationship between injury severity and perceived pain intensity of an acute 
muscular or ligamentous injury. Additionally, this study sought to determine if attentional 
capacity performance is influenced by acute musculoskeletal pain. This study was performed in 
two parts. Part I involved evaluating participants within the first 24 hours of initial injury, or re-
exacerbation of a previous injury, and recording their current level of perceived pain intensity.19 
Following the initial evaluation and care of injury but still within the first 24 hours of injury, 
participants that fit the inclusion and exclusion criteria were asked to participate in Part II and 
tested on attentional capacity. Participants in Part II were re-tested on the same cognitive tests 
once they were no longer experiencing pain, between one and three weeks following initial 
injury. Grade of injury severity, perceived pain intensity rating, and attentional capacity scores 
from both testing periods were the variables used in this study. 
Participants  
Participants were recruited from those seeking any type of medical care from a certified 
athletic trainer (AT) at a single university recreation center in the southeast United States (n = 
56). Sixteen individuals (n = 13 male, mean age 19.75 ± 1.36 years; n = 3 female, mean age 
19.33 ± 0.58 years) were clinically diagnosed with an acute muscular or ligamentous injury and 
agreed to participate in Part I of this study. Acute pain was operationally defined as the onset or 
exacerbation of pain within 24 hours of sufficient severity to necessitate the search for medical 
care.19 Five recreationally active participants (n = 5 male, mean age 20 ± 1.23 years) agreed to 
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participate in Part II. An individual was considered recreationally active if they participated in a 
minimum of 30 minutes of moderate-intensity aerobic physical activity 5 days a week, or 20 
minutes of vigorous-intensity aerobic physical activity 3 days a week.20  Exclusion criteria for 
Part II only consisted of the following: suspected fracture, head injury, or altered mental status; 
injury to the participant’s dominant hand; diagnosed concussion within the previous 6 months; 
color-blind or decreased visual acuity; self-report of an attentional or learning disorder; self-
report of depression, anxiety, or any other psychiatric disorder; use of analgesic medication 
within 24 hours of testing; and those whose primary language was not English.21-25 Figure 1 
provides a visual representation of how eligibility was determined for Parts I and II. Tables 1 and 
2 provide descriptive data including ethnicity and year in school for Part I and Part II, 
respectively. 
 
Table 1. Descriptive Data of Participants for Part I. 
 n % 
Ethnicity White 8 50.0 
Black 4 25.0 
Hispanic 2 12.5 
Asian/Pacific 1 6.3 
No Response 1 6.3 
School Year Freshman 3 18.8 
Sophomore 6 37.5 
Junior 4 25.0 
Senior 2 12.5 
No Response 1 6.3 
Notes: n = number of participants; % = percentage of participants. 
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Table 2. Descriptive Data of Participants for Part II. 
 n % 
Ethnicity White 1 20.0 
Black 2 40.0 
Hispanic 1 20.0 
Asian/Pacific 1 20.0 
School Year Sophomore 3 60.0 
Junior 1 20.0 
Senior 1 20.0 
Notes: n = number of participants; % = percentage of participants. 
 
Figure 1. Flow Chart Representing Participant Recruitment 
 
 
 
Initial 
Evaluation
(n = 56)
Part I
(n = 16)
Acute muscular or 
ligamentous injury
Agreed to participation
Part II 
(n = 5)
Inclusion
Recreationally 
active
18-30 years old
Exclusion
Suspected fracture, head injury, or 
altered mental status
Injury to the dominant hand
Diagnosed concussion within 6 
months
Color-blind or decreased visual 
acuity
Attentional or learning disorder
Depression, anxiety, or other 
psychiatric disorder
Analgesic medication within 24 
hours of testing
Primary language not English
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Experimental Protocol 
 The primary investigator for this study was an AT for the university’s recreation center. 
All individuals that sought care following initial injury or exacerbation of a previous injury were 
evaluated and provided care by the athletic training staff. Initial perceived pain intensity was 
determined with the Visual Analog Scale (VAS_1). The clinical diagnosis and severity of injury 
were assigned based on commonly used grading scales and following a thorough clinical 
evaluation that included relevant history questions, observation, relevant palpations, and special 
tests. All individuals diagnosed with an acute muscular or ligamentous injury were considered 
potential participants.  
Following completion of the evaluation and care of the injury, only individuals with a 
diagnosed muscular or ligamentous injury were asked if they would be interested in participating 
in the study. If interest was expressed, Part I of the study began with the completion of the 
informed consent and a brief health questionnaire (found in Appendix C). Those injuries 
determined to be a grade 1 (G1) were considered mild, grade 2 (G2) moderate, and grade 3 (G3) 
severe. Participants who passed eligibility criteria for Part II were then asked if they would like 
to continue with Part II of the study. Those participants that agreed were taken to a quiet room to 
continue data collection where external distractions were limited. Each participant’s perceived 
pain intensity was determined again with the Visual Analog Scale (VAS_2) immediately prior to 
attentional testing. Attentional capacity was then measured with neuropsychological tests: the 
Trail-Making Test Part A (TMT-A), Trail-Making Test Part B (TMT-B), and the Color-Word 
Interference Test (CWIT). The order of test administration was alternated between participants.  
Participants were asked to return when pain free, no earlier than one week and no longer 
than three weeks post injury, to repeat the VAS (VAS_3) and all attention tasks. A follow up 
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health questionnaire was completed at this time as well (Appendix C). An email was sent to 
participants one week following the initial testing session to schedule the second testing session. 
If needed, participants received up to two additional emails as a reminder and for scheduling 
purposes. Participants who were still experiencing pain at the one week check-in were allowed 
up to two additional weeks to schedule their followed-up attentional testing. 
Instrumentation 
VAS. The Visual Analog Scale is a 100 mm continuous line anchored on either end with 
the cues of “no pain” indicating a score of 0 and “worst possible pain” indicating a score of 
100.26 The score is determined by measuring the distance (mm) between the two endpoints with 
the following cut points: no pain at 0-4 mm, mild pain at 5-44 mm, moderate pain at 45-74 mm, 
and severe pain at 75-100 mm.26 The inherent continuum of an analog scale allows for greater 
sensitivity and reliability in representing current perceived pain intensity than similar descriptive 
pain scales.27 
TMT. The Trail-Making Test includes two parts: TMT-A performed by connecting 
consecutive numbers from 1-25, and TMT-B performed similarly by connecting alternating 
numbers and letters in sequence (e.g. 1-A-2-B-3-C and so on).28 This test is scored by the time to 
complete each trial in seconds with any errors pointed out immediately and reflected in the final 
score. The purpose of this test is to measure attention, processing speed, and mental flexibility.29 
Construct validity of the TMT-B supports the test as a complex measure of visual scanning and 
attention when compared to the paced auditory serial addition test (0.58) and the visual search 
and attention test (0.50).30 The mean interrater reliability as measured by intraclass correlation 
coefficient was high for TMT-A (0.94) and TMT-B (0.90).31 Standard administration time for 
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this test is approximately 5-10 minutes. Although only TMT-B was included in the statistical 
analysis, TMT-A was also administered in accordance with standard administration procedures.  
CWIT. The Color-Word Interference Test comes from the Delis-Kaplan Executive 
Functions Systems (D-KEFS) neuropsychological test battery. This test is designed based off of 
the Stroop paradigm, one of the most widely used techniques in the measurement of attention 
and response inhibition.32 Four conditions are included in this test: (CWIT-1) the naming 
condition where the participant names the color of 50 different boxes, either red, green, or blue; 
(CWIT-2) the reading condition where the participant must read 50 different color names – red, 
green, or blue – printed in black ink; (CWIT-3) the interference condition where the participant 
must name the ink color of 50 color words where the ink color is never the same as the written 
word color; (CWIT-4) the switching condition which is the same as CWIT-3 except when any 
word is in a frame, the word is read instead of naming the color of the ink.16 The score of this test 
is determined by time to complete each condition in seconds, resulting in 4 separate scores. 
Collectively, this test is designed to measure selective attention, cognitive flexibility, working 
memory, processing speed, and resistance to interference.29 The internal consistency for this test 
is considered adequate (0.70 - 0.79) and an ICC correlation revealed adequate test-retest 
reliability (0.70 - 0.79) with 9-74 days between testing sessions.29  Standard administration time 
for this test is approximately 5-10 minutes. 
Statistical Analysis 
 All statistical tests were processed using Statistical Package for the Social Sciences 
(SPSS) IBM Corp., v.25 (Chicago, IL, USA). Demographic information including ethnicity and 
year in school was included in a descriptive statistical analysis. The reliable change index (RCI) 
was used to determine the clinical significance of any change in performance with a 90% 
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confidence interval to control for neuropsychological testing practice effects.33 First, the reliable 
change (RC) was determined using equation 1 where T1 was the score while in acute pain, T2 the 
score while pain-free, and SDIFF the SD of the difference scores. Equation 2 was used to then 
determine the RCI, or absolute value of the difference score required for a change in score to be 
considered reliable.  
 
𝑅𝐶 =  
𝑇1−𝑇2
𝑆𝐷𝐼𝐹𝐹
       (1) 
𝑅𝐶𝐼 =  𝑆𝐷𝐼𝐹𝐹 × 1.645     (2) 
 
A Spearman’s Rho correlation was used to determine the relationship between the 
diagnosed severity of an injury and the corresponding perceived pain intensity. The Wilcoxon 
signed-rank test was used to compare the perceived pain intensity and attentional capacity scores 
while in pain (T1) and once pain-free (T2). Comparisons investigated the differences between 
VAS_2 and VAS_3 to confirm a change in pain between sessions, and the differences between 
the TMT-B at each time point and all four conditions of the CWIT at each time point to 
determine if changes existed in attentional capacity between sessions. The alpha level to 
determine statistical significance for both the Spearman’s Rho and the Wilcoxon signed-rank test 
was set a priori at p < 0.05. Effect sizes were calculated using Cohen’s d where a small effect is 
defined as d = 0.2, a medium effect is d = 0.5, and a large effect when d = 0.8. 
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CHAPTER 3 
RESULTS 
 Upon initial evaluation of all 16 participants included in Part I of this study, 25% (n = 4) 
presented with “mild” pain, 62.5% (n = 10) presented with “moderate” pain, and 12.5% (n = 2) 
presented with “severe” pain as recorded by the VAS_1. Of all 16 participants, 68.8% (n = 11) 
were clinically diagnosed with a G1 injury, 25% (n = 4) with a G2 injury, and 6.3% (n = 1) with 
a G3 injury. A Spearman’s rank-order correlation was run to determine the relationship between 
all 16 participants’ grade of injury and VAS_1. The results indicated that no relationship was 
demonstrated (rs = 0.054, p = 0.841). 
 Of the 5 participants that were included in Part II of this study, 80% (n = 4) were 
clinically diagnosed with a G1 injury and 20% (n = 1) with a G2 injury. None of the participants 
were clinically diagnosed with a G3 injury. Perceived pain as determined by the VAS_2 was 
rated as follows: 20% (n = 1) as “mild” pain, 60% (n = 3) as “moderate” pain and 20% (n = 1) as 
“severe” pain.  
 The Wilcoxon signed-rank test indicated a significant change between the acute pain state 
(T1) and the pain-free state (T2) on the VAS, the CWIT-1, and the CWIT-4 as indicated in Table 
3. A decrease in mean time to complete while pain-free as compared to while in acute pain was 
seen in the CWIT-1 (T1: 26.40 secs ± 3.29; T2: 23.60 secs ± 2.79) and the CWIT-4 (T1: 54.80 
secs ± 8.23; T2: 48.20 secs ± 6.1). Each of these results additionally had a large effect size as 
determined by Cohen’s d. No statistically significant differences were observed in the remainder 
of the attentional tests when comparing the acute pain and pain-free sessions. Means and 
standard deviations (SD) for all variables in Part II are shown in Table 3.  
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Table 3. Pain Perception and Attentional Capacity Scores for Each Session 
Pair Time Mean (s) SD p Cohen’s d 
VAS 
T1 48.60 25.12 
0.043* 2.72 
T2 0.20 0.45 
TMT-B 
T1 45.80 12.38 
0.068 0.55 
T2 40.00 8.28 
CWIT-1 
T1 26.40 3.29 
0.042* 0.92 
T2 23.60 2.79 
CWIT-2 
T1 20.40 3.65 
0.461 0.15 
T2 19.80 4.15 
CWIT-3 
T1 40.40 7.57 
0.141 0.20 
T2 38.80 8.11 
CWIT-4 T1 54.80 8.23 0.043* 0.91 
T2 48.20 6.01 
Notes: VAS = Visual Analog Scale; TMT-B = Trail Making Test B; CWIT-1 = Naming 
condition; CWIT-2 = Reading condition; CWIT-3 = Inhibition condition; CWIT-4 = 
Inhibition/Switching condition; T1 = acute pain; T2 = pain-free.  
* represents a significant difference between time points (p < 0.05).  
 
The reliable change index (RCI) with a 90% CI determined that one of five participants 
had a reliable change for the CWIT-1, and CWIT-2 scores. Two of the five participants had a 
reliable change for the CWIT-3, and four of five had a reliable change for the CWIT-4. The 
difference scores and RCI for each CWIT condition are detailed in Table 4. For TMT-B, the RCI 
was 35.60 seconds with a 90% CI. None of the participants had a difference in score great 
enough to be considered a reliable change (DIFF = 7, 3, 15, 4, and 0 respectively).  
Table 4. RCI of the CWIT with a 90% Confidence Interval 
Participant RCI CWIT-1 DIFF CWIT-2 DIFF CWIT-3 DIFF CWIT-4 DIFF 
P6_C 2.98 2 0 3* 10* 
P8_C 3.49 3 3 3 6* 
P9_C 2.98 1 -2 0 12* 
P10_C 3.49 3 -1 -2 4* 
P13_C 2.98 5* 3* 4* 1 
Notes: RCI = Reliable Change Index; CWIT-1 = naming condition; CWIT-2 = reading 
condition; CWIT-3 = inhibition condition; CWIT-4 = inhibition/switching condition; DIFF = 
difference in scores (T1 – T2).  
* represents a score greater than the RCI, indicating a reliable change.  
18 
 
 
CHAPTER 4 
DISCUSSION 
The purpose of this study was to determine the relationship between the perceived pain 
intensity and the clinically diagnosed severity of an acute musculoskeletal injury. It further 
sought to determine if attentional capacity performance is influenced by the presence of acute 
pain. It was hypothesized that there is no relationship between the pain and severity of an acute 
musculoskeletal injury, and that attentional capacity performance would improve once pain-free 
as compared to an acute pain state.  
Consistent with the hypothesis, no relationship was observed between the diagnosed 
severity of injury and the associated perceived pain intensity. Mixed results were seen when 
comparing performance on attentional capacity tests completed while experiencing acute pain to 
once pain-free. Scores on the CWIT-1 and CWIT-4, when pain-free, significantly improved from 
those recorded while participants were experiencing acute pain. Previous studies have reported a 
decrease in cognitive performance related to chronic and acute pain, although none focused 
solely on how attention was impacted by acute pain in the recreationally active population.15-18 
To the researcher’s knowledge, no previous studies have differentiated between injury severity 
and the associated perceived pain intensity reported during the clinical evaluation of an acute 
musculoskeletal injury.  
Injury Severity and Perceived Pain 
  No relationship was observed between the diagnosed severity of an acute musculoskeletal 
injury and the associated pain experienced. Although individual differences in the perception of 
pain intensity have previously been recognized, no studies have examined the relationship 
between pain and diagnosed injury severity.34 In an attempt to confirm the validity of patients’ 
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subjective report of pain as recorded by the VAS, one study revealed that almost all patients 
diagnosed with injury also reported ailments, but many patients that reported ailments did not get 
a diagnosis.4 This would suggest that the subjective report of pain had a high sensitivity and low 
specificity when determining the presence of actual tissue damage, but no description of the 
severity of injury was mentioned in that study. The results of the present study then contribute to 
the limited literature in demonstrating the lack of congruency between perceived pain and 
assessed tissue damage.   
 The wide variance in pain perception between individuals may further be explained using 
the neuromatrix theory of pain. This theory suggests that the pain experience is determined by 
the combination of sensory, motivational, and cognitive information.3 Each of these factors 
contributes to one overarching network, or neuromatrix, that is genetically determined and 
continuously modified by sensory experiences.3,35 Components such as present context, past 
history, and future implications play a large role in the pain experienced with an acute injury.36 It 
is suggested that pain is the product of a widely distributed neural network in the brain rather 
than the result of injury, inflammation, or any type of pathology.3 The lack of relationship 
observed in this study between perceived pain intensity and diagnosed injury severity, which was 
used to describe the extent of assessed tissue damage, lends support to this theory. 
Pain and Attention 
Mixed results were observed regarding the effect of pain perception on attentional capacity. 
Improvements were seen in time to complete the CWIT-1 and CWIT-4 when participants were 
pain-free as compared to while in acute pain. These differences were further supported by large 
effect sizes of 0.92 and 0.91 respectively. The CWIT-1, or the color naming condition, provides 
a baseline for basic naming skills.29 Low scores on this test generally indicate a word-finding 
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impairment, a developmental disability, limited exposure to the English language, or some other 
neurostructoral factor that may affect mental processing speed.29 The CWIT-4, or 
inhibition/switching task, requires adequate naming speed, reading speed, verbal inhibition, and 
cognitive flexibility.29 As there was no significant change in the CWIT-2, or reading condition, it 
was not suspected that acute pain had a detrimental effect on reading abilities or speed. Further, 
no significant change existed in the CWIT-3, or inhibition task, indicating that acute 
musculoskeletal pain did not have an effect on verbal inhibition. There was an attempt to control 
for developmental disabilities and limited exposure to the English language. These results then 
suggest that acute pain may have an adverse effect on word-finding, naming speed, and cognitive 
flexibility, but not on reading abilities or verbal inhibition.  
Previous studies using the stroop effect have observed performance reductions of inhibition 
in chronic pain patients.37 In fibromyalgia patients, a close association was also seen between 
pain severity and the magnitude of performance decline on cognitive tests.37 Compared to the 
current study, it appears that chronic and acute pain may affect different aspects of attentional 
capacity, as the current participants did not demonstrate a significant decline in inhibition. This 
may be due to a variance in pain severity or the duration of the pain experience. It is also 
possible that the level of pain experienced by the current participants was not high enough to 
have an effect on inhibition tasks.  
When examining differences between each time point, the RCI reveals individual participants 
that reached what would be considered a reliable change in attentional task performance. One 
participant was determined to have a reliable change on CWIT-2, and two participants were 
considered to have a reliable change on CWIT-3. These results indicate that despite the lack of 
significance in group changes, individual participants did show improvements once pain-free. 
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This is a clinically relevant finding that should be further explored in future research with a 
larger sample size. On the CWIT-4, four of the participants had a reliable improvement in their 
scores once pain-free, further supporting that complex attention may be affected by acute pain.  
Unlike previous studies, no statistically significant change was seen in the TMT-B, a 
measure of attention, speed, and mental flexibility. Although not statistically significant (p = 
0.068), the mean improvement of 5.8 seconds on the TMT-B while pain-free may be clinically 
relevant, and was supported by a medium effect size of 0.55. A decline in performance on this 
task has been reported in patients with both chronic and acute pain.15,18 Chronic pain patients 
were slower in completing the TMT-B as compared to healthy controls, indicating slow to 
moderate impairments in set shifting.15 Slower completion was also seen in patients suffering 
acute pain as compared to their own pain-free state, indicating a similar effect between acute and 
chronic pain on set shifting.18 The difference in findings between the current study and previous 
literature may be due to the small sample size reported in this study or a practice effect of the test 
metric. As the results of this study were near significance with a medium effect size, a larger 
sample size may better reveal impairments in this attentional task. A better method to control for 
the practice effects of the test metric may also have an impact on these outcomes. 
Scores from both the CWIT and the TMT-B were compared to normative data. Scaled scores 
for the CWIT were determined based on age and time to complete each condition with a highest 
possible score of 19.38 Participants’ mean scaled scores while pain free were average for CWIT-1 
and CWIT-2, and just above average for CWIT-3 and CWIT-4 (CWIT-1: 11.8 ± 1.30; CWIT-2: 
11.2 ± 2.49; CWIT-3: 12.8 ± 1.92; CWIT-4: 12.0 ± 1.22). While in acute pain, participants’ 
mean scaled scores were average for CWIT-1, CWIT-2, and CWIT-4 and just above average for 
CWIT-3 (CWIT-1: 10.8 ± 1.64; CWIT-2: 11.0 ± 2.35; CWIT-3: 12.6 ± 1.82; CWIT-4: 10.4 ± 
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2.07). For the TMT-B, participants in the current study completed the task in less time when 
pain-free (40.00 ± 8.28 secs), and while in acute pain (45.80 ± 12.38 secs) than the available 
population norms (48.97 ± 12.69 secs).39 Therefore, practice effects may have a substantial 
influence over the results of this study.  
 There were several assumptions and limitations within this study. It was assumed that all 
participants gave their full effort when completing each attentional test. As the exclusion criteria 
were determined through self-report, it was also assumed that participants were honest in 
reporting their current amount of physical activity, relevant previous medical history, and did not 
purposely exaggerate their current levels of pain. Limitations were present in both the design and 
execution of this study.  
In determining the severity of each musculoskeletal injury, a clinical evaluation was 
performed by a single athletic trainer, and no imaging was used to confirm the severity of each 
diagnosis. Although imaging tools are useful to confirm the magnitude and exact location of 
injury, and in the prediction of recovery time and risk of recurrence, routine imaging is not 
justified nor often performed upon initial clinical evaluation in traditional athletic training 
practice.40,41 Evidence suggests that a clinical examination is just as accurate as an MRI in 
predicting time to return to competition following a muscular strain.8,40 As it is not common 
practice to request imaging following minor musculoskeletal injuries, it was decided that the use 
of a clinical evaluation would be more applicable to current practices. Furthermore, referrals to a 
physician for follow-up evaluations are primarily based on the grading of the injury upon initial 
evaluation, which was more relevant to our research questions.  
 No control was used to limit the effects of caffeine on attentional performance. As 
caffeine is a stimulant that reduces mental fatigue, it has been suggested to modulate the 
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inhibitory control of attention when consumed in doses above 200-250 mg.42,43 Due to 
methodological differences such as habitual consumption of participants and timing of dosages, 
it is unclear to what extent caffeine affects cognitive performance.43 Those who habitually 
consume high levels of caffeine may also be negatively affected by the lack of caffeine 
consumption prior to performance on an attentional task due to withdrawal effects.44 There is 
some evidence to suggest that sustained attention is also improved when tested immediately 
following exercise.42 The previous study reporting decreased performance on the TMT-B while 
in acute pain administered cognitive tasks within 72 hours following initial injury, whereas this 
study administered all tests within 24 hours of initial injury.18 It is possible that the beneficial 
immediate effects of exercise on attention overshadowed some adverse effects of pain.  
Within any type of neuropsychological testing, practice effects remain a major limitation. 
Within this study, not all of the participants reached the minimum improvement necessary to be 
considered a reliable change. Therefore practice effects were likely to have played a role within 
the final results and influence the conclusions that can be made from this study. Another 
limitation within this study involves the sample size. With so few participants included, the 
results of this study should be considered exploratory only, and further research with a larger 
sample size would be necessary to reach proper power. Finally, all attentional testing was 
completed in an office located next to a busy recreational gym where not all noise and potential 
distractors could be completely controlled. This study was delimited to a recreationally active 
population between the ages of 18 – 30 years at a single university in southeast Georgia. As 
such, the results of this study may not be generalizable to a more sedentary population or to those 
under the age of 18 or over the age of 30.  
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CHAPTER 5 
CONCLUSION 
 The results of this study indicated that no relationship existed between the diagnosed 
severity of an acute musculoskeletal injury and the associated perceived pain intensity. Further, 
pain following an acute musculoskeletal injury in a recreationally active population may have 
adverse effects on attentional components such as word-finding, naming speed, and cognitive 
flexibility, but not on reading abilities or verbal inhibition. The results of this study are 
preliminary, and a larger sample size would be required to further explore the relationships 
between diagnosed injury severity, the associated perceived pain intensity, and the resultant 
effect on attentional capacity.  
Clinical implications suggest that the inclusion of pain descriptors in the definition of 
grading scales may introduce a bias to a clinician’s initial evaluation of an acute musculoskeletal 
injury. Accurate grading scales are vital in determining appropriate prognostic and therapeutic 
directions. An initial clinical evaluation should prioritize objective findings such as the presence 
or absence of functional and structural integrity rather than the reported pain intensity in 
determining the clinical diagnosis. Clinicians should also be aware of the potential for impaired 
attention following an acute musculoskeletal injury. Impairments in cognitive flexibility may 
alter a patient’s ability to focus on vital information conveyed to them, rather than the attention-
demanding pain they are experiencing. When providing important information to patients who 
are experiencing acute pain, these results support the use of a written format rather than oral 
delivery alone.  
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APPENDIX A 
Revised Research Questions and Hypotheses 
• RQ1: Is there a relationship between the perceived pain intensity and the diagnosed 
injury severity of an acute musculoskeletal injury? 
• H1: No relationship exists between the perceived pain intensity and the diagnosed injury 
severity of an acute musculoskeletal injury.  
 
• RQ2: Is attentional capacity performance influenced by the presence of acute pain as 
compared to a pain-free state? 
• H2: An improvement in attentional capacity performance will exist when a participant is 
pain-free as compared to while experiencing acute pain.  
Inclusion Criteria 
• Participants that are 18-30 years of age and recreationally active 
• Presentation of acute pain due to muscular or ligamentous injury 
Exclusion Criteria 
• Suspected fracture, head injury, or altered mental status 
• Injury to the dominant hand 
• Diagnosed concussion within the last 6 months 
• Decreased visual acuity or reported color-blindness 
• Reported diagnosis of attentional or learning disorder 
• Reported diagnosis of depression, anxiety, or other psychiatric disorder 
• Analgesic medication used within 24 hours of testing 
• First language is not English 
32 
 
 
Limitations 
• Participant’s failure to return for repeat testing 
• Lack of imaging to confirm severity of injury 
• Clinical diagnosis of injury severity determined by a single novice athletic trainer 
Delimitations 
• A young adult population that is recreationally active at a single university 
Assumptions 
• Participant honesty regarding level of physical activity, self-report of pain, and previous 
medical history.  
• Participant effort during all cognitive testing  
Operational Definitions 
• Recreationally Active: participates in at least 30 minutes of moderate-intensity aerobic 
physical activity on 5 days a week or at least 20 minutes of vigorous-intensity aerobic 
physical activity on 3 days a week.20 
• Acute Pain: within 24 hours of initial injury or re-exacerbation of prior injury.19
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APPENDIX B 
LITERATURE REVIEW 
Background 
 Physical activity within the general population is frequently promoted to maintain health 
and reduce the risk of obesity. It has recently been estimated that over 300 million Americans 
took part in sports and other fitness activities in 2018, which is 1.6 million more participants than 
in 2017.1 As the number of people participating in physical activities continues to increase, there 
is a simultaneous increase in the number of athletic injuries.2 This higher incidence of injury and 
the associated pain experience has become an important public health concern as it often results 
in high costs (i.e., medical bills, days of work lost), fear of participation, or a negative view of 
sports and exercise.2,45 
Many of the negative aspects of athletic injury are due to the pain experienced. Pain is 
considered acute when it is the expected physiological response following injury; if it then 
persists beyond a normal healing time, it is considered chronic.11,15 There is evidence to suggest 
that chronic pain may alter cognitive function.15,37,46,47 Studies have documented chronic pain 
patients’ report of cognitive difficulties and impaired performance on neuropsychological tests.16 
Management of chronic pain has begun to incorporate attention and distraction tasks as emerging 
evidence suggests a modulating effect between pain and attention.48 Currently, very few studies 
have considered the effect of acute pain on cognitive function.17,18  
Executive functions are high-level cognitive processes that are necessary for flexible 
behavior, including adaptation to new or changing situations.49 Attention may be considered as 
one domain within executive functioning as it is a means by which specific information is 
selected for further processing in the brain.29 The concept of attention includes both the ability to 
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concentrate on one task and to ignore distractors. Pain is a known attention-demanding process 
suggested to interfere with cognitive tasks, especially those involving attention.5,10 
The following is a review of the current literature on the interaction between pain and 
executive function, specifically within the attentional domain. The main topics include: a general 
overview of the classification of musculoskeletal injury; the definition and process of pain; 
definitions for cognition and executive functioning; the interaction between pain and cognitive 
functions; assessments of executive function and pain intensity.  
 
Musculoskeletal Injury 
The musculoskeletal system involves all bones, muscles, tendons, and ligaments of the 
body. Injury occurs when these tissues sustain damage due to some physical trauma.50 Injuries to 
the musculoskeletal system specifically may include fractures, dislocations, sprains, or strains. A 
thorough clinical examination is necessary in determining what structures are involved and how 
severe the damage may be. This examination then forms the base for a clinical diagnosis.6 
Within a typical evaluation, the following five steps are used to ensure that no potentially serious 
injuries are missed: palpation of bony structures, palpation of ligamentous structures, assessment 
of range of motion, testing of musculature, and special tests.51 This clinical assessment is also 
useful to obtain an accurate prognosis of injury.41 
Many common musculoskeletal injuries, such as sprains and strains, are assigned a grade 
of severity based on the findings of the clinical examination. These grading systems are 
beneficial to clinicians and athletes as they provide both prognostic and therapeutic direction.52 
Currently, there are no standardized grading systems for sprains or strains; however, clinicians 
commonly assign the grade of severity based on anatomical damage, clinical presentation, 
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functional loss, mechanism of trauma, stability, proposed treatment needed, or any combination 
of these factors.53 The American Medical Association Standard Nomenclature System is 
frequently used in the grading of a ligamentous sprain, and is based on anatomic damage.54 
Within this system, Grade 1 indicates a stretched ligament, Grade 2 a partial tearing of the 
ligament, and Grade 3 describes a completely torn ligament.54 Based on clinical presentation 
only, Jackson, Ashley, and Powell devised a classification system using the terms mild, moderate 
and severe.55 A mild sprain is characterized by minimal or no swelling, minimal functional loss, 
point tenderness, and pain with reproduction of the mechanism of injury; a moderate sprain 
includes moderate functional loss, localized swelling, and point tenderness; and finally a severe 
sprain includes diffuse tenderness and swelling, and an unwillingness to support weight.55  
 For the classification of a muscle strain, imaging such as MRI or ultrasonography may be 
used to provide information on the size, severity, and precise location of injury.41 This use of 
imaging may be advocated for to further understand the extent of damage, which is useful in 
determining prognostic factors such as recovery time.56 Studies have found a strong correlation 
between a clinical examination and MRI results to predict actual time to return to competition.41 
Routine imaging in clinical practice is often not justified due to the acceptable accuracy of a 
clinical examination.40,41 Regardless of clinical or radiological diagnosis, the most widely used 
muscle injury grading systems are based on three grades of injury determined to be minor (Grade 
1), moderate (Grade 2), or complete (Grade 3).52,57 Grade 1 is considered a strain with few 
muscle fibers involved, complaints of swelling and discomfort, and minimal strength and 
function impairment. Grade 2 is a partial tear with some continuity among the muscle fibers at 
the injury site, impairments in strength and athletic activities involving high-speed and high 
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resistance, and obvious lack in muscle function such as ability to contract. Grade 3 is considered 
a complete tear with a loss of all muscle function.56 
  
Pain 
Definition and Process 
 The International Association for the Study of Pain (IASP) defines pain as “an unpleasant 
sensory and emotional experience associated with actual or potential tissue damage, or described 
in terms of such damage.” 9 Three important qualities of the pain experience are highlighted in 
this definition: it has unique sensory and perceptual characteristics, it is an unpleasant emotional 
experience, and no absolute relationship exists between pain experience and tissue damage.5 
Therefore it is not surprising that this complex process, involving both sensory and emotional 
components, will vary greatly between people and within a single individual depending on the 
context of the pain and the individual’s current mental state.12  
Pain is classified as either chronic or acute depending on its duration. According to the 
IASP, pain is considered chronic when it persists beyond the normal or expected healing time, or 
is typically assigned at three months.15 The ultimate indication of chronic pain is structural, 
functional, or chemical changes to the brain and central nervous system.15 Acute pain is the 
expected physiological response to adverse chemical, thermal, or mechanical stimuli which may 
be associated with any surgery, trauma, or illness.11 The immediate experience of acute pain is 
strongly influenced by the attitudes, beliefs, and personalities of the patient.11  
Pain is a multidimensional experience produced by multiple influences.35 Any threat to 
tissue integrity results in the firing of nociceptive neurons, discharging at a rate that is 
proportionate to the intensity of the stimulus.11 The inflammatory response is initiated by tissue 
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destruction, and sustained by immune cells and multiple mediators such as monoamines, 
cytokines, prostanoids, and peptides.11 These mediators work to sensitize functional nociceptors 
or activate any that are dormant.11 Through the interaction of these inflammatory mediators and 
receptors, the nociceptive input is integrated and modulated into the peripheral nervous system.11 
C and a-δ fibers send the nociceptive information to the dorsal horn located within the spinal 
cord, where it is then relayed on ascending pathways to the thalamic, limbic, and cortical 
structures responsible for a reaction.11 
Within the brain, certain areas including the primary (S1) and secondary (S2) 
somatosensory cortices, anterior cingulate cortex (ACC), insula, prefrontal cortex (PFC), 
thalamus, and cerebellum are activated by noxious stimuli.12 These brain pathways are connected 
to different aspects of the pain experience: S1 and S2 encode the sensory features such as 
location and duration of pain; the ACC and insula are components of the limbic system that 
encode the emotional and motivational aspects of pain.12 Pain may also occur without any 
noxious stimulation, as seen in amputee patients with phantom limb pain.58 
 
Theories of Pain 
 In 1965, Ronald Melzack and Patrick Wall developed the gate control theory.59 Within 
this theory, it is suggested that stimulation of an individual’s skin elicits nerve impulses that are 
then conducted through three spinal cord systems (Figure 1). These systems include the 
substantia gelatinosa in the dorsal horn, the afferent dorsal-column fibers, and the first central 
transmission (T) cells also located in the dorsal horn.59 The substantia gelatinosa is the gate that 
modulates the afferent pattern of the nerve impulses. The afferent dorsal-column fibers, or the 
fibers that project towards the brain, are the central control trigger. As such, they have the power 
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to activate selective brain processes and influence how the nerve impulses are modulated at the 
gate, or substantia gelatinosa. The T cells activate the mechanisms responsible for the response 
to and perception of these nerve impulses. The interaction between all three systems aids in the 
determination of pain phenomena.59 
 
Figure 2. Schematic Diagram of Melzack and Wall's Gate Control Theory59 
 
Note: Large-diameter (L) and small-diameter (S) fibers project to the substantia gelatinosa (SG) 
which modulates afferent patterns before they influence the T cells (T). The T cells activate the 
action system responsible for response and perception. The central control trigger influences the 
modulating properties of the gate control system. Data from Melzack and Wall, 196559 
 
 This theory is crucial as it places the central nervous system as a key component to the 
pain process, forcing the medical and biological communities to accept the brain as an active 
system in processing sensory inputs.35 It describes a process that involves the brain rather than 
just the peripheral nervous system. It further describes the dorsal horns as a site that dynamic 
processes such as inhibition, excitation, and modulation can occur, rather than just a passive 
system.35 However, this theory does not completely capture what determines an individual’s 
39 
 
 
perception of pain, especially when no noxious stimulus is present. For that, Melzack proposed 
the concept of the neuromatrix.  
 
 
The neuromatrix theory of pain describes pain as a multidimensional experience that is 
determined by the individual’s unique neurosignature (Figure 2).3 The experience of any sensory 
event is derived from the combination of afferent information from the peripheral system and 
cognitive information such as present context, past history, and future implications.36 These 
factors all influence one overarching network, labeled the neuromatrix, which is genetically 
determined then altered by sensory inputs and experiences.3,35 As the brain continuously 
processes and synthesizes incoming information through the neuromatrix, a characteristic pattern 
develops creating an individual’s unique neurosignature. This neurosignature is continuously 
flowing and adapting based on the incoming information, providing a continually adapting self-
Figure 3. Neuromatrix Theory of Pain3 
 
Note: The body-self neuromatrix is shaped by cognitive (C), sensory (S), and affective (A) 
neuromodules. The resultant output patterns influence the neurosignature, shaping the pain 
experience and behavioral response. Data from Melzack, 2001.3 
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awareness.3 This theory places genetics and the neural-hormonal mechanisms associated with 
stress as equally important as those associated with sensory transmission.35 With so many factors 
involved, it becomes evident that pain is produced by a wide neural network in the brain rather 
than the direct result of sensory input from injury, inflammation, or some other pathology.3 
 
Pain Perception 
For centuries, vast differences in pain perception have been recognized.34 Using the Fear-
Avoidance Model, the perception of pain may be broken down into two basic components: the 
sensory component and the emotional reaction component.60 The emotional component may 
further be divided into pain experience, pain behavior, and the physiological response to painful 
stimuli.60 Each of these components is designed to work together, and any imbalance may result 
in an exaggerated pain perception.60 
Biological differences are also responsible for some of the variations in pain perception. 
For example, sex has been suggested to impact ratings of pain perception. In one study women 
are reported as recording higher mean subjective pain ratings than their male counterparts.61 In 
the comparison of young male and female subjects with an experimental noxious heat stimuli 
applied, females rated the heat stimuli as more intense than the males did, regardless of the 
gender of the experimenter.62,63 Positron emission tomography (PET) scans show a significantly 
greater activation of the PFC in females as compared to males, suggesting that this difference in 
pain perception may be due to sensory factors rather than the result of an attitude or emotional 
response.62,63 
In addition to emotional and biological differences, cognition also has an important 
impact on the perception of pain.12 Perception involves both active processing of sensations and 
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filtering of sensations away from the conscious mind. In order to achieve these processes, 
attentional factors must play a large role.64 Within the perception of pain, attention must be 
turned towards the pain to evaluate its intensity and qualities.10 Further, pain demands attention 
due to the biological importance of nociception.10 As pain is able to actively consume attention, 
it naturally has easy access to consciousness.16 
 
Cognition and Executive Functions 
  Within the realm of neuropsychology, cognition involves the information processing of 
behavior.64 It is considered a functional property of individuals as it cannot be directly observed, 
but must rather be inferred from behavior.64 The functional components of cognition involve 
what and how much knowledge, skill, and intellect a person may have.65 Executive functions are 
a type of high-level cognitive processing that facilitates new behaviors and works to optimize 
one’s approach to any new or unfamiliar circumstances. It is through these functions that people 
are able to behave flexibly and adapt to new or changing situations.49 As such, they are 
responsible for many of the factors that enable a person to lead an independent and purposeful 
life.49 Executive functions can further be described as an interaction between the goal-directed 
activity of the brain and attention-demanding peripheral input.15 These processes are thought to 
be supported in the frontal lobes of the brain.49 Although there are several subclasses of 
executive functions, three distinguishable cognitive components are often highlighted, including 
information updating and monitoring (‘Updating’), inhibition of prepotent responses 
(‘Inhibition’), and mental set shifting (‘Shifting’).66 
 Updating is closely linked to working memory. It requires both monitoring and coding 
incoming information based on the relevance of the current task, and then revising the 
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information already stored in working memory; any old or irrelevant information is replaced 
with new or more relevant information.66 Working memory, and therefore updating, is often 
associated with the prefrontal cortex.66 Inhibition involves the deliberate suppression of 
dominant, automatic, or prepotent responses whenever necessary.66 It involves blocking a 
habitual response in favor of a less familiar one.66 Shifting involves switching back and forth 
between multiple tasks, operations, or mental sets, and is thought to involve the frontal lobes of 
the brain.66,67 This process is closely related to attentional control as it includes subsequently 
disengaging from the old or irrelevant task and actively engaging in the new, more relevant 
task.66 
Attention may be thought of as the gateway of information flow to the brain.29 Models of 
attention frequently divide it into component processes including: alertness/arousal, focused 
attention, selective attention, divided attention, and sustained attention.29 It should be noted that 
many of these tasks may overlap and no consensus has been reached on the exact meaning of 
each of these terms.29 Different attention-demanding tasks have been found to engage the same 
group of brain regions, including the PFC, the ACC, and the posterior parietal.13,14 The brain has 
inherent limitations on the amount of information that can be processed at a given time. The 
ability to select specific information to further process, or directing attention towards specific 
information, is necessary to function effectively.29 Attention is considered a common capacity or 
resource that must be divided between tasks. When the demands of tasks exceed the resource 
availability, thought and behavior may slow, stop, or become flawed.5 
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Pain and Cognition 
 Evidence from fMRI, PET, and EEG studies suggest that pain and cognitive activity 
interact in the brain with a modulating effect on one another.10 Pain is an attention-demanding 
process, requiring enhanced neural resources in brain structures that overlap with executive 
functions.5,15 The PFC plays a key role in both the neuromatrix of pain and executive 
functioning.37 Therefore, it is not surprising that cognitive performance may be disrupted by the 
presence of pain. It is currently unknown if the cognitive load or intensity of pain alters the level 
of interaction.10 Studies have suggested that activity in afferent pain pathways are also altered by 
attentional state, both positive and negative emotions, empathy, and a placebo effect.12 
 The current available research on pain and cognition generally focuses on chronic pain 
patients. Within the clinical community, it is widely accepted that chronic pain is associated with 
a decline in cognitive performance.15,16,47,68 In one outpatient multidisciplinary chronic pain 
program, 62% of the patients reported moderate to severe difficulties in at least 1 out of 5 
cognitive domains.68 These cognitive impairments may then lead to difficulties in social 
situations and everyday functions, even in chronic pain patients with no history of neurological 
disorders.16 These deficits are associated with both subjective cognitive impairments and 
objective neuropsychological test performance.16,47 A comparison across five studies with 
chronic pain patients specifically suggested impaired set shifting with a medium effect size.15 
 Several studies concerning pain and cognition focused on fibromyalgia syndrome, a 
condition involving chronic, widespread pain in the muscles, tendons, and joints. Reduced 
performance on tasks of memory and attention, both selective and sustained, has been observed 
in affected patients.37 A close association between the severity of pain and magnitude of 
performance decline supports the idea that it is the interference effect of pain that is altering 
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cognitive function.37 The severity of pain had a larger impact on attention, arithmetic abilities, 
and implicit memory than other modifying factors such as depression and anxiety, suggesting 
that those factors play a subordinate role.37 
Very little research is currently available evaluating the effect of acute pain on cognitive 
functioning.17,18 One study compared the performance of a healthy control group, a group of 
athletes with a concussion, and a group of athletes with an acute musculoskeletal injury on a 
computerized neuropsychological test battery.17 Interestingly, the musculoskeletal injury group 
performed significantly worse than the control, but not significantly different then the concussion 
group.17 In another study, recreationally active participants that were administered a 
neuropsychological test battery, both in a pain free state and following an acute musculoskeletal 
injury, performed worse on measures of immediate recall and complex attention when following 
acute injury.18 These results bring to light the potential for cognitive deficits in any patient 
suffering acute pain due to a musculoskeletal injury. 
 
Assessments 
Trail Making Test (TMT) 
The Trail Making Test is a pen-and-paper neuropsychological assessment designed to 
measure attention, processing speed, and mental flexibility.29 It is one of the five most commonly 
used measures by neuropsychologists, and ranks as the top instrument to measure attention.69,70 
This test is administered in two parts, Trail Making Test A (TMT-A) and Trail Making Test B 
(TMT-B). In TMT-A, a line is drawn connecting consecutive numbers from 1-25. In TMT-B, a 
similar line is drawn connecting alternating numbers and letters (i.e. 1-A-2-B and so on). The 
45 
 
 
score is based on the time to complete each trail; any errors are immediately pointed out for 
correction and reflected in the final score.28  
This test is designed for use with adults aged 15-89 years, and only takes 5-10 minutes 
for administration. The test-retest reliability for this assessment was found to be adequate for 
both TMT-A (0.7) and TMT-B (0.8).71 This test is both efficient and sensitive in reliably 
differentiating between individuals with brain impairment and those without.28 A majority of the 
studies examining set shifting in chronic pain patients utilize a version of the TMT, resulting in 
lower scores for both TMT-A and TMT-B as compared to healthy controls, with more errors on 
TMT-B.15 The clinical interpretations drawn from this test appear to be valid when compared to 
a set-switching task, confirming that this test may be confidently used to assess executive 
function.28 
A normative set of data was developed for the TMT consisting of 680 individuals, ages 
18-89 years. The sample contains both male and female participants and an education level 
ranging from 5-25 years. Trails A and B were both administered following standard guidelines, 
with the instruction to complete each part as quickly and accurately as possible.39 Table 1 
displays a sample from the normative data set for ages 18-34 years old.  
  
 
Table 5. Statistical properties of the TMT normative data set stratified by age, 
education, gender, and Trails A and B (s).  
Age Groups Mean ± SD Median Min-Max 
Ages 18-24 (n=155)    
Age 20.17 ± 1.48 20.00 18-24 
Education 12.92 ± 1.01 13.00 10-15 
Gender 1.59 ± 0.49   
Trail A (s) 22.93 ± 6.87 21.70 12-57 
Trail B (s) 48.97 ± 12.69 46.00 29-95 
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Ages 25-34 (n=33)    
Age 29.42 ± 2.87 30.00 25-34 
Education 14.18 ± 1.61 14.00 11-18 
Gender 1.58 ± 0.50   
Trail A (s) 24.40 ± 8.71 23.00 10-45 
Trail B (s) 50.68 ± 12.36 50.00 29-78 
 
Color-Word Interference Test (CWIT) 
 The Delis-Kaplan Executive Function System (D-KEFS) is a collection of 9 tasks 
designed to assess the different components of executive functioning.29 This system was 
designed to allow for flexible use so that the included tests could be used together or 
individually.29 This system was standardized with a nationally represented, stratified sample 
including 1,750 participants: children, adolescents, and adults aged 8-89 years.  Age, sex, 
race/ethnicity, years of education, and geographic region were all accounted for based on the 
2000 U.S. Census.38 The Color-Word Interference Test (CWIT) is one assessment included 
within the system that is designed to evaluate attentional processing and psychomotor speed.16,29 
 The CWIT involves 4 conditions: color naming, word reading, inhibition, and 
inhibition/shifting respectively. Color naming involves naming the color of 50 different colored 
spots (red, green, or blue). Word reading involves reading color words (red, green, or blue) 
printed in black ink. Inhibition involves naming the color of ink that color words are printed in 
where the color of ink never matches the color word. Inhibition/switching adheres to the same 
rule as the inhibition task, except for any word that has a frame around it which must be read 
instead of the color of ink named. The participant is instructed to complete each of these tasks as 
quickly as possible without making mistakes. 
 The CWIT was designed based off of the Stroop Effect, one of the oldest and most 
commonly used methods of evaluating attention and response inhibition.32 Originally developed 
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by J. Ridley Stroop in 1935, the stroop effect is observed when an individual must inhibit the 
natural response of reading a color word while actively processing the color of ink that the word 
is printed in.72 It is a measure of cognitive control and suppressing a habitual response in favor of 
a less familiar one.29 This effect is included in several neuropsychological testing batteries due to 
its reliable and robust assessment of attentional processing.73 
 Although the D-KEFS test battery has received some criticism for few reliability values 
reaching values greater than 0.8, this variability should be expected due to the broad spectrum of 
cognitive processes being measured.74 Reaching a greater psychometric stability is limited due to 
the demands of measuring executive functions. The CWIT specifically has shown adequate test-
retest reliability (0.70-0.79) and a high internal consistency (0.62-0.86).29,74 Moderate 
correlations were reported between the D-KEFS test battery and the Wisconsin Card Sorting Test 
suggesting the validity of this system.74 In the measurement of individual executive functions, 
evidence suggests this test battery to be the most thorough and precise.74 
 
Visual Analog Scale (VAS) 
 The visual analog scale (VAS) is a 100 mm line that the patient places a mark on to 
measure how much pain they are currently experiencing, or their current pain intensity. The two 
ends of the line represent two extremes, labelled to correspond to the absolute minimum and 
maximum amount of pain possible, with an infinite number of points between the extremes.75,76 
The score is obtained by measuring from 0 mm to the point marked by the patient.77 This tool is 
considered to be the best method available for recording perceived pain or pain relief.78 
 The continuum of an analog scale results in a greater sensitivity than other measurements 
that rely on descriptive terms.76,78-80 The visual analog scale is considered to be the most 
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sensitive method of measuring perceived pain intensity.75 The reliability of this scale is well 
established, with ratings as high as r = 0.97 with between-session experimental pain trials, and is 
rated as the preferred tool for participants.76,77,79,81  
 
Summary 
 Musculoskeletal injuries such as sprains and strains are often categorized as mild, 
moderate, or severe. The level of pain associated with injury is often included in the 
determination of the severity of injury, despite the wide variations seen in the perception of pain. 
A threat to tissue integrity will fire nociceptive neurons initiating the pain process; however, pain 
is a multidimensional experience that is affected by sensory, cognitive, and even emotional 
factors according to the neuromatrix theory of pain.3,11 
 While cognition determines what and how much knowledge, skill, and intellect a person 
may have, it is the higher-level cognitive processes of executive functioning that allow flexible 
behavior and the ability to adapt with new and changing circumstances.49,64 One domain within 
executive functions includes attention, a resource that is divided between multiple tasks.5 Due to 
the brain’s inherent limitations of the resources available, the ability to direct attention towards 
specific information for further processing is crucial to function effectively.29 Thought and 
behavior will become slow, flawed, or stopped when the resource limit has been met.5 
 Both pain and cognition activate the ACC and PFC, requiring the neural resources to be 
shared between both processes.13,14 Evidence from fMRI, PET, and EEG studies further suggests 
that an interaction and modulation occurs when both processes are present.10 The current 
literature supports decreased cognitive function in chronic pain patients and in patients subjected 
to laboratory-induced pain such as a cold pressor task.12,15,82,83 There is limited support for a 
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decrease in cognitive function with acute musculoskeletal pain as well.17,18 More studies should 
be conducted to further explore any modulating effects between acute clinical pain and cognitive 
tasks. The VAS is a useful method in determining the current level of pain intensity experienced 
by the patient.26 Instruments such as the TMT and CWIT are well established methods of 
measuring cognitive functions, such as attention, and demonstrate good validity and adequate 
reliability.28,29,71 
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APPENDIX C: Questionnaires and Assessments 
INFORMED CONSENT  
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FIGURE 4: THE VISUAL ANALOG SCALE (VAS) 
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FIGURE 5: THE TRAIL MAKING TEST A (TMT-A) 
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FIGURE 6: THE TRAIL MAKING TEST B (TMT-B) 
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FIGURE 7: THE COLOR-WORD INTERFERENCE TEST (CWIT) 
 
Condition 1:      Condition 2: 
   
 
Condition 3:      Condition 4: 
  
 
 
 
 
 
56 
 
 
 
57 
 
 
 
58 
 
 
 
59 
 
 
60 
 
 
APPENDIX D: IRB Letters 
 
61 
 
 
REFERENCES 
1. Physical Activity Council (PAC). 2019 physical activity council's overview report on U.S. 
participation. 2019. 
2. Tracey J. The emotional response to the injury and rehabilitation process. J Appl Sport 
Psychol. 2003;15(4):279-293. 
3. Melzack R. Pain and the neuromatrix in the brain. J Dent Educ. 2001;65(12):1378-1382. 
4. Björkstén M, Boquist B, Talbäck M, Edling C. The validity of reported musculoskeletal 
problems: A study of questionnaire answers in relation to diagnosed disorders and perception of 
pain. Appl Ergon. 1999;30(4):325-330. 
5. Eccleston C, Crombez G. Pain demands attention: A cognitive–affective model of the 
interruptive function of pain. Psychol Bull. 1999;125(3):356. 
6. Ekstrand J, Healy JC, Walden M, Lee JC, English B, Hagglund M. Hamstring muscle injuries 
in professional football: The correlation of MRI findings with return to play. Br J Sports Med. 
2012;46(2):112-117. doi: 10.1136/bjsports-2011-090155. 
7. Starkey C, Brown SD, Ryan JL, Starkey C. Examination of orthopedic and athletic injuries. 
3rd ed. Philadelphia: F.A. Davis Co.; 2010. 
8. Kerkhoffs GM, van Es N, Wieldraaijer T, Sierevelt IN, Ekstrand J, van Dijk CN. Diagnosis 
and prognosis of acute hamstring injuries in athletes. Knee Surg Sports Traumatol Arthrosc. 
2013;21(2):500-509. 
62 
 
 
9. Merskey H. PART III: Pain terms, a current list with definitions and notes on usage. In: IASP 
press; 1994:207-214. 
10. Seminowicz DA, Davis KD. Pain enhances functional connectivity of a brain network 
evoked by performance of a cognitive task. J Neurophysiol. 2007;97(5):3651-3659. 
11. Carr DB, Goudas LC. Acute pain. The Lancet. 1999;353(9169):2051-2058. 
12. Bushnell MC, Ceko M, Low LA. Cognitive and emotional control of pain and its disruption 
in chronic pain. Nat Rev Neurosci. 2013;14(7):502-511. doi: 10.1038/nrn3516. 
13. Cabeza R, Nyberg L. Imaging cognition II: An empirical review of 275 PET and fMRI 
studies. J Cogn Neurosci. 2000;12(1):1-47. 
14. Naghavi HR, Nyberg L. Common fronto-parietal activity in attention, memory, and 
consciousness: Shared demands on integration? Conscious Cogn. 2005;14(2):390-425. 
15. Berryman C, Stanton TR, Bowering KJ, Tabor A, McFarlane A, Moseley GL. Do people 
with chronic pain have impaired executive function? A meta-analytical review. Clin Psychol 
Rev. 2014;34(7):563-579. 
16. Landrø NI, Fors EA, Våpenstad LL, Holthe Ø, Stiles TC, Borchgrevink PC. The extent of 
neurocognitive dysfunction in a multidisciplinary pain centre population. is there a relation 
between reported and tested neuropsychological functioning? Pain. 2013;154(7):972-977. 
17. Hutchison M, Comper P, Mainwaring L, Richards D. The influence of musculoskeletal injury 
on cognition: Implications for concussion research. Am J Sports Med. 2011;39(11):2331-2337. 
63 
 
 
18. Morogiello J, Murray N, Hunt T, Harris B, Szekely B, Shaver G. The effect of acute pain on 
executive function. J Clin Transl Res. 2018;4(2). 
19. Bijur PE, Silver W, Gallagher EJ. Reliability of the visual analog scale for measurement of 
acute pain. Acad Emerg Med. 2001;8(12):1153-1157. 
20. Haskell WL, Lee I, Pate RR, et al. Physical activity and public health: Updated 
recommendation for adults from the american college of sports medicine and the american heart 
association. Circulation. 2007;116(9):1081. 
21. Stuss D, Floden D, Alexander M, Levine B, Katz D. Stroop performance in focal lesion 
patients: Dissociation of processes and frontal lobe lesion location. Neuropsychologia. 
2001;39(8):771-786. 
22. Anstey KJ, Dain S, Andrews S, Drobny J. Visual abilities in older adults explain age-
differences in stroop and fluid intelligence but not face recognition: Implications for the vision-
cognition connection. Neuropsychol Dev Cogn B Aging Neuropschol Cogn. 2002;9(4):253-265. 
23. Van Boxtel M, Ten Tusscher M, Metsemakers J, Willems B, Jolles J. Visual determinants of 
reduced performance on the stroop color-word test in normal aging individuals. J Clin Exp 
Neuropsychol. 2001;23(5):620-627. 
24. van Duinen H, Lorist M, Zijdewind I. The effect of caffeine on cognitive task performance 
and motor fatigue. Psychopharmacology (Berl ). 2005;180(3):539-547. 
64 
 
 
25. Rogers PJ, Martin J, Smith C, Heatherley SV, Smit HJ. Absence of reinforcing, mood and 
psychomotor performance effects of caffeine in habitual non-consumers of caffeine. 
Psychopharmacology (Berl ). 2003;167(1):54-62. 
26. Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain. Arthritis Care Res. 
2011;63(S11). 
27. Sriwatanakul K, Kelvie W, Lasagna L, Calimlim JF, Weis OF, Mehta G. Studies with 
different types of visual analog scales for measurement of pain. Clin Pharmacol Ther. 
1983;34(2):234-239. 
28. Arbuthnott K, Frank J. Trail making test, part B as a measure of executive control : 
Validation using a set-switching paradigm. J Clin Exp Neuropsychol. 2000(4):518. 
29. Strauss E, Sherman EM, Spreen O. A compendium of neuropsychological tests: 
Administration, norms, and commentary. American Chemical Society; 2006. 
30. O'Donnell J, Macgregor L, Dabrowski J, Oestreicher J, Romero J. Construct validity of 
neuropsychological tests of conceptual and attentional abilities. J Clin Psychol. 1994(4):596. 
31. Fals-Stewart W. An interrater reliability study of the trail making test (parts A and B). 
Percept Mot Skills. 1992;74(1):39-42. 
32. MacLeod CM. Half a century of research on the stroop effect: An integrative review. Psychol 
Bull. 1991;109(2):163-203. doi: 10.1037/0033-2909.109.2.163. 
65 
 
 
33. Duff K. Evidence-based indicators of neuropsychological change in the individual patient: 
Relevant concepts and methods. Arch Clin Neuropsychol. 2012;27(3):248-261. 
34. Edwards RR, Fillingim RB. Self‐reported pain sensitivity: Lack of correlation with pain 
threshold and tolerance. Eur J Pain. 2007;11(5):594-598. 
35. Melzack R. From the gate to the neuromatrix. Pain. 1999;82:S121-S126. 
36. Coghill RC, McHaffie JG, Yen YF. Neural correlates of interindividual differences in the 
subjective experience of pain. Proc Natl Acad Sci U S A. 2003;100(14):8538-8542. doi: 
10.1073/pnas.1430684100. 
37. Guevara C, Fernandez-Serrano M, Reyes dP, Duschek S. Executive function impairments in 
fibromyalgia syndrome: Relevance of clinical variables and body mass index. PLoS ONE. 
2018;13(4). doi: 10.1371/journal.pone.0196329. 
38. Delis D, Kaplan E, Kramer J. D-KEFS technical manual. San Antonio: Psych Corp. 2001. 
39. Tombaugh TN. Trail making test A and B: Normative data stratified by age and education. 
Arch Clin Neuropsychol. 2004;19(2):203-214. 
40. Malliaropoulos N, Papacostas E, Kiritsi O, et al. Posterior thigh muscle injuries in elite track 
and field athletes. Am J Sports Med. 2010;38(9):1813-1819. 
41. Schneider-Kolsky ME, Hoving JL, Warren P, Connell DA. A comparison between clinical 
assessment and magnetic resonance imaging of acute hamstring injuries. Am J Sports Med. 
2006;34(6):1008-1015. 
66 
 
 
42. Kumar N, Wheaton LA, Snow TK, Millard-Stafford M. Exercise and caffeine improve 
sustained attention following fatigue independent of fitness status. Fatigue. 2015;3(2):104-121. 
43. Brunyé TT, Mahoney CR, Lieberman HR, Taylor HA. Caffeine modulates attention network 
function. Brain Cogn. 2010;72(2):181-188. 
44. Juliano LM, Griffiths RR. A critical review of caffeine withdrawal: Empirical validation of 
symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl ). 
2004;176(1):1-29. 
45. Sheu Y, Chen L, Hedegaard H. Sports- and recreation-related injury episodes in the united 
states, 2011-2014. Natl Health Stat Report. 2016(99):1-12. 
46. Eccleston C. Chronic pain and distraction: An experimental investigation into the role of 
sustained and shifting attention in the processing of chronic persistent pain. Behav Res Ther. 
1995;33(4):391-405. 
47. Moriarty O, Finn DP. Cognition and pain. Curr Opin Support Palliat Care. 2014;8(2):130-
136. doi: 10.1097/SPC.0000000000000054. 
48. Rode S, Salkovskis PM, Jack T. An experimental study of attention, labelling and memory in 
people suffering from chronic pain. Pain. 2001;94:193-203. doi: 10.1016/S0304-3959(01)00356-
6. 
49. Gilbert SJ, Burgess PW. Executive function. Current Biology. 2008;18(3):R110-R114. 
50. Whiting WC, Zernicke RF. Biomechanics of musculoskeletal injury. Human Kinetics; 2008. 
67 
 
 
51. Harmon KG. The ankle examination. Prim Care. 2004;31(4):1025-1037. 
52. Pollock N, James SL, Lee JC, Chakraverty R. British athletics muscle injury classification: A 
new grading system. Br J Sports Med. 2014;48(18):1347-1351. doi: 10.1136/bjsports-2013-
093302. 
53. Mann G, Nyska M, Constantini N, Matan Y, Renström P, Lynch S. Mechanics of injury, 
clinical presentation, and staging. In: The unstable ankle. Champaign, IL: Human Kinetics; 
2002:54-61. 
54. Rachun A. Standard nomenclature of athletic injuries. American Medical Association; 1976. 
55. Jackson DW, Ashley RL, Powell JW. Ankle sprains in young athletes: Relation of severity 
and disability. Clin Orthop Relat Res. 1974;101:201-215. 
56. Chan O, Del Buono A, Best TM, Maffulli N. Acute muscle strain injuries: A proposed new 
classification system. Knee Surg Sports Traumatol Arthrosc. 2012;20(11):2356-2362. 
57. Peetrons P. Ultrasound of muscles. Eur Radiol. 2002;12(1):35-43. 
58. Osborn J, Derbyshire SW. Pain sensation evoked by observing injury in others. Pain. 
2010;148(2):268-274. 
59. Melzack R, Wall PD. Pain mechanisms: A new theory. Science. 1965;150(3699):971-979. 
60. Lethem J, Slade P, Troup J, Bentley G. Outline of a fear-avoidance model of exaggerated 
pain perception—I. Behav Res Ther. 1983;21(4):401-408. 
68 
 
 
61. Etherton J, Lawson M, Graham R. Individual and gender differences in subjective and 
objective indices of pain: Gender, fear of pain, pain catastrophizing and cardiovascular 
reactivity. Appl Psychophysiol Biofeedback. 2014;39(2):89-97. doi: 10.1007/s10484-014-9245-x. 
62. Feine JS, Bushnell MC, Miron D, Duncan GH. Sex differences in the perception of noxious 
heat stimuli. Pain. 1991;44(3):255-262. 
63. Paulson PE, Minoshima S, Morrow TJ, Casey KL. Gender differences in pain perception and 
patterns of cerebral activation during noxious heat stimulation in humans. Pain. 1998;76(1-
2):223-229. 
64. Lezak MD. Neuropsychological assessment. Oxford University Press, USA; 2004. 
65. Lezak MD. The problem of assessing executive functions. Int J Psychol. 1982;17(2-3):281-
297. doi: 10.1080/00207598208247445. 
66. Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD. The unity and 
diversity of executive functions and their contributions to complex “frontal lobe” tasks: A latent 
variable analysis. Cognit Psychol. 2000;41(1):49-100. 
67. Monsell S. Control of mental processes. In: Unsolved mysteries of the mind: Tutorial essays 
in cognition. Psychology Press; 1996:93-148. 
68. Roth RS, Geisser ME, Theisen-Goodvich M, Dixon PJ. Cognitive complaints are associated 
with depression, fatigue, female sex, and pain catastrophizing in patients with chronic pain. Arch 
Phys Med Rehabil. 2005;86(6):1147-1154. 
69 
 
 
69. Camara WJ, Nathan JS, Puente AE. Psychological test usage: Implications in professional 
psychology. Prof Psychol Res Pr. 2000;31(2):141. 
70. Rabin LA, Barr WB, Burton LA. Assessment practices of clinical neuropsychologists in the 
united states and canada: A survey of INS, NAN, and APA division 40 members. Arch Clin 
Neuropsychol. 2005;20(1):33-65. 
71. Giovagnoli AR, Del Pesce M, Mascheroni S, Simoncelli M, Laiacona M, Capitani E. Trail 
making test: Normative values from 287 normal adult controls. Ital J Neurol Sci. 
1996;17(4):305-309. 
72. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18(6):643. 
73. Henik A. Paying attention to the stroop effect? J Int Neuropsychol Society. 1996;2(5):467-
470. 
74. Shunk AW, Davis AS, Dean RS. TEST REVIEW: Dean C. delis, edith kaplan & joel H. 
kramer, delis kaplan executive function system (D-KEFS), the psychological corporation, san 
antonio, TX, 2001. $415.00 (complete kit). Appl Neuropsychol. 2006;13(4):275-227. 
75. Huskisson E. Measurement of pain. The lancet. 1974;304(7889):1127-1131. 
76. Joyce C, Zutshi D, Hrubes V, Mason R. Comparison of fixed interval and visual analogue 
scales for rating chronic pain. Eur J Clin Pharmacol. 1975;8(6):415-420. 
77. Revill S, Robinson J, Rosen M, Hogg M. The reliability of a linear analogue for evaluating 
pain. Anaesthesia. 1976;31(9):1191-1198. 
70 
 
 
78. Scott J, Huskisson E. Graphic representation of pain. Pain. 1976;2(2):175-184. 
79. Littman GS, Walker BR, Schneider BE. Reassessment of verbal and visual analog ratings in 
analgesic studies. Clin Pharmacol Ther. 1985;38(1):16-23. 
80. Wallenstein SL, Kaiko R, Houde RW. Clinical evaluation of mild analgesics: The 
measurement of clinical pain. Br J Clin Pharmacol. 1980;10(S2). 
81. Price DD, McGrath PA, Rafii A, Buckingham B. The validation of visual analogue scales as 
ratio scale measures for chronic and experimental pain. Pain. 1983;17(1):45-56. 
82. Nouwen A, Cloutier C, Kappas A, Warbrick T, Sheffield D. Original report: Effects of 
focusing and distraction on cold Pressor–Induced pain in chronic back pain patients and control 
subjects. Journal of Pain. 2006;7:62-71. doi: 10.1016/j.jpain.2005.08.004. 
83. DeCharms C, Maeda F, Glover G, et al. Control over brain activation and pain learned by 
using real-time functional MRI. Proc Natl Acad Sci U S A. 2005(51):18626. 
  
